Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ħÀ±¼º ¼Ò¿±À¯¾ÏÀÇ ÀÓ»óÀû °íÂû A Clinical Study of Infiltrating Lobular Breast Cancer

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 1È£ p.90 ~ 97
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ߸ð/Jung Mo Kim ±è¿µÃ¶/³ëµ¿¿µ/À±¿©±Ô/¿À½Â±Ù/ÃÖ±¹Áø/Young Chul Kim/Dong-Young Noh/Yeo-Kyu Youn/Seung Keun Oh/Kuk Jin Choe

Abstract

¼­·Ð
À¯¹æ¾ÏÀº Çѱ¹ ¿©¼º¿¡ ¹ß»ýÇÏ´Â ¾ÏÁß 3À§¸¦ Â÷ÁöÇϸç, ¿ì¸®³ª¶ó¿¡¼­ À¯¾ÏÀº ¹ß»ýÀÌ °è¼Ó
Áõ°¡µÇ¾î ¿ÔÀ¸¸ç, Áúº´ÀÇ ¹ß»ý ÇüÅ°¡ ¼­±¸¿Í ºñ½ÁÇÏ¿© Áö°í ÀÖ´Ù°í º¼ ¶§ ¾ÕÀ¸·Îµµ À¯¾ÏÀÇ
ºóµµ´Â °è¼Ó Áõ°¡µÇ¸®¶ó°í ¿¹»óµÈ´Ù. ħÀ±¼º ¼Ò¿±À¯¾ÏÀº ÈçÈ÷ °æ°è°¡ ºÒºÐ¸íÇÑ Á¾±«¸¦ ÁÖ¼Ò
·Î ³»¿øÇϸç, ´Ù¹ß¼º ¹× ¾çÃø¼º º´º¯À» Áö´Ï´Â °æ¿ìµµ ¸¹´Ù. ±×·¯³ª À¯°ü¾Ï¿¡ ºñÇØ »ó´ëÀûÀ¸
·Î ºóµµ°¡ Àû±â ¶§¹®¿¡ ÈçÈ÷ °æÇèÇÏ´Â ¾ÏÁ¾Àº ¾Æ´Ï´Ù. ÀÌ¿¡ µû¶ó ÀúÀÚµéÀº ħÀ±¼º ¼Ò¿±À¯¾Ï
ÀÇ ÀÓ»óÀû ¾ç»ó°ú Á¶Á÷º´¸®ÇÐÀû Ư¡À» »ìÆ캸°í, ÀÌ È¯ÀÚ±ºÀÇ ¿¹Èĸ¦ »ìÆ캸°íÀÚ ÇÑ´Ù.

Purpose: Infiltrating lobular carcinoma of the breast was blown to have a high
incidence of multicentricity and bilaterality in patients. We analyzed the clinical features
of infiltrating lobular breast cancer.
Materials and Methods: We studied 29 patients with infiltrating lobular carcinoma of
the breast, from Jan. 1980 to Mar. 1997 in the Department of Surgery, Seoul National
University Hospital.
Results: The age of the patients ranged from 32 to 71 years with an average of 45.2
years. The main complaining symptom was a painless mass. The diameter of the tumor
ranged from 0.7 to 7 §¯ with a mean size of 2.8 §¯. The axillary lymph node was
positive for malignancy in 12 cases. The number of multicentric breast cancers were 7
cases (241%), and the number of bilateral breast cancers were 3 cases (10.3%). The
estrogen receptor was positive in 66.7%, and the progesterone receptor was positive in
75% of the cases. There were one local recurrence and three distant metastases during
a mean follow-up period of 4.5 years. The 5-year survival rate and 5-year disease free
survival rate were 89.6% and 88.6%, respectively.
Conclusion: Infiltrating lobular breast cancers are at greater risk of developing
multicentricity and bilaterality than nonlobular breast cancers. Careful program of
frequent follow-up examinations and thorough histopathological studies are needed for
patients with infiltrating lobular breast cancers.

Å°¿öµå

Infiltrating lobular breast cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS